Equine doping: perceptions, adverse effects and Cyprus hippodrome case review for the years 2001-2010

PDF
Published: Dec 27, 2017
DOI: https://doi.org/10.12681/jhvms.15578
Keywords:
anabolic steroids Cyprus racing equine doping equine performance manipulation
K. SPANOUDES (Κ. ΣΠΑΝΟΥΔΗΣ)
Network of Excellence for Functional Biomaterials, National University of Ireland
N. DIAKAKIS (Ν. ΔΙΑΚΑΚΗΣ)
Faculty of Veterinary Medicine, Aristotle University of Thessaloniki
Abstract

Doping in race horses affects thousands of equine athletes worldwide. Illicit administration of medical compounds aims to improve the horse’s performance either through altering the athletic capacity, or through covering the symptoms of pathologic conditions. Nicosia race track has a significant number of confirmed doping cases when considering the small equine population of the island, reflecting the lack of credibility of racing in Cyprus. The most frequently administered medications are anabolic steroids, human recombinant erythropoietin, stimulants, diuretics, non-steroidal anti-inflammatory drugs, local anesthetics, bronchodilators and coagulants. Interestingly, published literature on the effectiveness of these substances is inconclusive or contradictory. This article constitutes a cumulative presentation of confirmed doping cases in Nicosia race track and a brief review on the published literature regarding the effectiveness of the most commonly administered compounds.

Article Details
  • Section
  • Research Articles

Authors who publish with this journal agree to the following terms:

· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Downloads
Download data is not yet available.
References
British Horseracing (2006-2010) Annual Reviews. London, United Kingdom.
Cyprus Turf Club (2001-2010) Annual Reports. Nicosia, Cyprus. Dowling P, Williams M, Clark T (1993) Adrenal insufficiency associated with long-term anabolic steroid administration in a horse. J Am Vet Med Assoc 203:1166-1169.
Dowling P (2002) Adverse drug reactions in horses. Clin Tech Eq Pract 1:58-67
Ferraz GC, Teixeira-Neto AR, Mataqueiro MI, Lacerda-Neto JC, Queiroz-Neto A (2008) Effects of intravenous administration of caffeine on physiologic variables in exercising horses. Am J Vet Res 69:1670-1675.
Hinchcliff K, Geor R, Kaneps A (2008) Equine Exersice Physiology. Elsevier, Missouri.
Hinchcliff K, Morley P, Guthrie A (2009) Efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage in Thoroughbred racehorses. J Am Vet Med Assoc 235:76-82.
Hodgson D, McGowan C, McKeever K (2014) The athletic Horse, 2nd edn. Elsevier, Missouri.
Hyyppa S, Rasanen LA, Persson SGB, Pӧsӧ AR (1995) Exercise performance indices in normal and anabolic steroid treated trotters. Eq Vet J 27:443-7.
Inhofe PD, Grana WA, Egle D, Min KW, Tomasek J (1995) The effects of anabolic steroids on rat tendon. An ultrastructural, biomechanical, and biochemical analysis. Am J Sports Med 23:227-232.
Jaussaud P, Audran M, Gareau RL, Souillard A, Chavanet I (1994) Kinetics and haematological effects of erythropoietin in horses. Vet Res 25:568-573.
Kearns CF, McKeever KH (2002) Clenbuterol diminishes aerobic performance in horses. Med Sci Sports Exerc 34:1976-1985.
McKeever KH, Agans JM, Geiser S, Lorimer PJ, Maylin GA (2006 ) Low dose exogenous erythropoietin elicits an ergogenic effect in standardbred horses. Eq Vet J 36:233-238.
Moses VS, Bertone AL (2002) Nonsteroidal anti-inflammatory drugs. Vet Clin North Am Eq Pract 18:21-37.
Murray M. (1999) Pathophysiology of peptic disorders in foals and horses: a review. Eq Vet J 29:14-18
Nimmo MA, Snow DH, Munro CD (1982) Effects of nandrolone phenylpropionate in the horse: (3) Skeletal muscle composition in the exercising animal. Eq Vet J 14:229-233.
Pascoe JR, McCabe AE, Franti CE, Arthur RM (1985) Efficacy of furosemide in the treatment of exercise-induced pulmonary hemorrhage in Thoroughbred racehorses. Am J Vet Res 46:2000-2003.
Perez-Moreno CI, Couetil LL, Pratt SM, Ochoa-Acuna HG, Raskin RE, Russell MA (2009) Effect of furosemide and furosemidecarbazochrome combination on exercise-induced pulmonary hemorrhage in Standardbred racehorses. Can Vet J 50:821-827.
Piercy RJ, Swardson SJ, Hinchcliff KW (1998) Erythroid hyploplasia and anemia following administration of recombinant human erythropoietin to two horses. J Am Vet Med Assoc 212:244-247.
Pitts SC, Davis M (2007) An evidence-based analysis of anabolic steroids as performance enhancers in horses. Eq Vet Educ 19:388-391.
Savage KA, Colahan PT, Tebbett IR, Rice BL, Freshwater LL, Jackson CA (2005) Effects of caffeine on exercise performance of physically fit Thoroughbreds. Am J Vet Res 66:569-573.
Segura D, Monreal L, Perez-Pujol S, Alonso A, Diaz-Ricart M, Brugues R, Ordinas A, Escolar G (2007) Effects of etamsylate on equine platelets: in vitro and in vivo studies. Vet J 174:325-329.
Seynnes OR, Kamandulis S, Kairaitis R, Helland C, Campbell E-L, Brazaitis M, Skyrvydas A, Narici MV (2013) Effect of androgenic-anabolic steroids and heavy strength training on patellar tendon morphological and mechanical properties. J Appl Physiol 115:84-89.
Sleeper MM, Kearns CF, McKeever KH (2002) Chronic clenbuterol administration negatively alters cardiac function. Med Sci Sports Exerc 34:643-650.
Souillard A, Audran M, Bressolle F, Jaussaud P, Gareau R. (1996) Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses. Biopharm Drug Dispos 17:805-815.
Snow DH, Munro CD, Nimmo MA (1982a) Effects of nandrolone phenylpropionate in the horse: (1) resting animal. Eq Vet J 14:219-223.
Snow DH, Munro CD, Nimmo MA (1982b). Effects of nandrolone phenylpropionate in the horse: (2) General effects in animals undergoing training. Eq Vet J 14:224-228.
Most read articles by the same author(s)